News Ticker

WIRE: Justice Department decision on Harborside bodes well for cannabis industry law

NEW YORK — The Cannabis industry had a major victory last week, without even appearing in court. The US Department of Justice, after four years, has dropped the case to shut down Harborside Health Center in Oakland, California, which is currently the largest marijuana dispensary in the United States.


Robert MacCoun, a law professor and drug-policy expert at Stanford University, in an interview with SF Gate perfectly explained how this market is changing: “The framework is moving from the war on drugs to tricky issues of regulation, taxation and who is going to be in control of this major new industry,” he said.

The reason for the softer approach is in part economical. According to a report by Marijuana Business Daily (actual real website) the entire marijuana industry, including tourism, which is an impact of legalization, is projected to provide $44 billion to the economy by 2020.

Legal marijuana sales in the US alone spiked to $5.4 billion in 2015, up from $4.6 billion in 2014. Sales are projected to hit $7.1 billion in 2016. Diego Pellicer Worldwide, Inc. (OTCQB: DPWW), Terra Tech Corp (OTCQX: TRTC), Medical Marijuana, Inc. (OTCMKTS: MJNA), GW Pharmaceuticals PLC (NASDAQ: GWPH), General Cannabis Corp (OTCQB: CANN).

An independent research article by Michael Markowski, who has been part of the Financial Information Industry for decades producing research, information and intelligence products gives his insight into the Cannabis space. His article can be found here: <Click here to view his article>.

He touches on names like Diego Pellicer Worldwide, Inc. (OTC: DPWW), a real estate and a consumer retail development company that is focused on developing Diego Pellicer as the world’s first “premium” marijuana brand by adhering to the highest quality and standards for its facilities along with both cannabis and non-cannabis products.

Other sector companies mentioned, Terra Tech Corp (OTC: TRTC), operates through multiple subsidiary businesses including: Blum, IVXX Inc., Edible Gardens, MediFarm LLC and GrowOp Technology.

Medical Marijuana, Inc. (OTC: MJNA), wants to be the premier cannabis and hemp industry innovators, leveraging their team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit.

In the Pharmaceutical world, GW Pharmaceuticals PLC (NASDAQ: GWPH) recently announced the successful completion of their phase 3 trial for the treatment of Dravet syndrome – a rare and severe form of epilepsy in children with no FDA-approved treatments. The company’s investigational medicine Epidiolex® proprietary cannabinoid product platform. Shares of the company jumped 120% after the announcement on March 14.

General Cannabis Corp (OTC: CANN), is the all-in-one resource for the highest quality service providers available to the regulated Cannabis Industry. They are a trusted partner to the cultivation, production and retail side of the cannabis business. They do this through a combination of strong operating divisions such as real estate, consulting, security, financing and the distribution of important infrastructure products to grow facilities and dispensaries.

For “The Latest Buzz in Financial News”, Please Visit:

About, a leading informational web portal and designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, TV Broadcasting, and Financial Publications.

Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the “Site”) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial media and marketing firm enters into service agreements with the companies which are the subject to the articles posted on the Site for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. We do not undertake to update any of the information on the Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on the Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print.  Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit:

Media Contact:


Leave a comment